Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid.

Durham SR, Gould HJ, Thienes CP, Jacobson MR, Masuyama K, Rak S, Lowhagen O, Schotman E, Cameron L, Hamid QA.

Eur J Immunol. 1997 Nov;27(11):2899-906.

PMID:
9394816
2.

Expression of IL-4, Cepsilon RNA, and Iepsilon RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical corticosteroids.

Cameron LA, Durham SR, Jacobson MR, Masuyama K, Juliusson S, Gould HJ, Lowhagen O, Minshall EM, Hamid QA.

J Allergy Clin Immunol. 1998 Mar;101(3):330-6.

PMID:
9525448
3.

Local synthesis of epsilon germline gene transcripts, IL-4, and IL-13 in allergic nasal mucosa after ex vivo allergen exposure.

Cameron L, Hamid Q, Wright E, Nakamura Y, Christodoulopoulos P, Muro S, Frenkiel S, Lavigne F, Durham S, Gould H.

J Allergy Clin Immunol. 2000 Jul;106(1 Pt 1):46-52.

PMID:
10887304
4.
5.

In vivo expression of signal transducer and activator of transcription factor 6 (STAT6) in nasal mucosa from atopic allergic rhinitis: effect of topical corticosteroids.

Ghaffar O, Christodoulopoulos P, Lamkhioued B, Wright E, Ihaku D, Nakamura Y, Frenkiel S, Hamid Q.

Clin Exp Allergy. 2000 Jan;30(1):86-93.

PMID:
10606935
6.

Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.

Masuyama K, Jacobson MR, Rak S, Meng Q, Sudderick RM, Kay AB, Lowhagen O, Hamid Q, Durham SR.

Immunology. 1994 Jun;82(2):192-9.

7.

IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy.

Ghaffar O, Laberge S, Jacobson MR, Lowhagen O, Rak S, Durham SR, Hamid Q.

Am J Respir Cell Mol Biol. 1997 Jul;17(1):17-24.

PMID:
9224205
8.
9.

Allergen drives class switching to IgE in the nasal mucosa in allergic rhinitis.

Takhar P, Smurthwaite L, Coker HA, Fear DJ, Banfield GK, Carr VA, Durham SR, Gould HJ.

J Immunol. 2005 Apr 15;174(8):5024-32.

12.

Expression of IgE heavy chain transcripts in the sinus mucosa of atopic and nonatopic patients with chronic sinusitis.

Ghaffar O, Durham SR, Al-Ghamdi K, Wright E, Small P, Frenkiel S, Gould HJ, Hamid Q.

Am J Respir Cell Mol Biol. 1998 May;18(5):706-11.

PMID:
9569241
13.

Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids.

Masuyama K, Till SJ, Jacobson MR, Kamil A, Cameron L, Juliusson S, Lowhagen O, Kay AB, Hamid QA, Durham SR.

J Allergy Clin Immunol. 1998 Oct;102(4 Pt 1):610-7.

PMID:
9802369
14.

Granulocyte/macrophage-colony stimulating factor in allergen-induced rhinitis: cellular localization, relation to tissue eosinophilia and influence of topical corticosteroid.

Nouri-Aria KT, Masuyama K, Jacobson MR, Rak S, Lowhagen O, Schotman E, Hamid Q, Durham S.

Int Arch Allergy Immunol. 1998 Dec;117(4):248-54.

PMID:
9876226
15.

Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge.

Rak S, Jacobson MR, Sudderick RM, Masuyama K, Juliusson S, Kay AB, Hamid Q, Löwhagen O, Durham SR.

Clin Exp Allergy. 1994 Oct;24(10):930-9.

PMID:
7842362
16.

Local expression of epsilon germline gene transcripts and RNA for the epsilon heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma.

Ying S, Humbert M, Meng Q, Pfister R, Menz G, Gould HJ, Kay AB, Durham SR.

J Allergy Clin Immunol. 2001 Apr;107(4):686-92.

PMID:
11295659
17.

Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.

Holm A, Dijkstra M, Kleinjan A, Severijnen LA, Boks S, Mulder P, Fokkens W.

J Allergy Clin Immunol. 2001 Apr;107(4):627-33.

PMID:
11295650
18.

Expression of IL-16 in allergen-induced late-phase nasal responses and relation to topical glucocorticosteroid treatment.

Laberge S, Durham SR, Ghaffar O, Rak S, Center DM, Jacobson M, Hamid Q.

J Allergy Clin Immunol. 1997 Oct;100(4):569-74.

PMID:
9338554
19.

Supplemental Content

Support Center